27662296|t|Preclinical Amyloid-beta and Axonal Degeneration Pathology in Delirium.
27662296|a|BACKGROUND: The clinical relevance of brain beta-amyloidosis in older adults without dementia is not established. As delirium and dementia are strongly related, studies on patients with delirium may give pathophysiological clues. OBJECTIVE: To determine whether the Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers amyloid-beta 1-42 (Abeta42), total tau (T-tau), and phosphorylated tau (P-tau) are associated with delirium in hip fracture patients with and without dementia. METHODS: CSF was collected in conjunction to spinal anesthesia in 129 patients. Delirium was assessed using the Confusion Assessment Method once daily in all patients, both pre- and postoperatively. The diagnosis of dementia at admission was based upon clinical consensus. CSF levels of Abeta42, T-tau, and P-tau were analyzed. RESULTS: In patients without dementia, we found lower CSF Abeta42 levels (median, 310 ng/L versus 489 ng/L, p = 0.006), higher T-tau levels (median, 505 ng/L versus 351 ng/L, p = 0.02), but no change in P-tau in patients who developed delirium (n = 16) compared to those who remained lucid (n = 49). Delirious patients also had lower ratios of Abeta42 to T-tau (p < 0.001) and P-tau (p = 0.001) relative to those without delirium. CSF Abeta42 and T-tau remained significantly associated with delirium status in adjusted analyses. In patients with dementia, CSF biomarker levels did not differ between those with (n = 54) and without delirium (n = 10). CONCLUSION: The reduction in CSF Abeta42, indicating beta-amyloidosis, and increase in T-tau, indicating neurodegeneration, in hip fracture patients without dementia developing delirium indicates that preclinical AD brain pathology is clinically relevant and possibly plays a role in delirium pathophysiology.
27662296	12	24	Amyloid-beta	Gene	351
27662296	29	48	Axonal Degeneration	Disease	MESH:D009410
27662296	62	70	Delirium	Disease	MESH:D003693
27662296	116	132	beta-amyloidosis	Disease	MESH:D000686
27662296	157	165	dementia	Disease	MESH:D003704
27662296	189	197	delirium	Disease	MESH:D003693
27662296	202	210	dementia	Disease	MESH:D003704
27662296	244	252	patients	Species	9606
27662296	258	266	delirium	Disease	MESH:D003693
27662296	338	357	Alzheimer's disease	Disease	MESH:D000544
27662296	359	361	AD	Disease	MESH:D000544
27662296	419	426	Abeta42	Gene	351
27662296	435	438	tau	Gene	4137
27662296	467	470	tau	Gene	4137
27662296	499	507	delirium	Disease	MESH:D003693
27662296	511	523	hip fracture	Disease	MESH:D006620
27662296	524	532	patients	Species	9606
27662296	550	558	dementia	Disease	MESH:D003704
27662296	630	638	patients	Species	9606
27662296	640	648	Delirium	Disease	MESH:D003693
27662296	718	726	patients	Species	9606
27662296	776	784	dementia	Disease	MESH:D003704
27662296	847	854	Abeta42	Gene	351
27662296	900	908	patients	Species	9606
27662296	917	925	dementia	Disease	MESH:D003704
27662296	946	953	Abeta42	Gene	351
27662296	1100	1108	patients	Species	9606
27662296	1123	1131	delirium	Disease	MESH:D003693
27662296	1172	1177	lucid	Disease	
27662296	1188	1197	Delirious	Disease	
27662296	1198	1206	patients	Species	9606
27662296	1232	1239	Abeta42	Gene	351
27662296	1309	1317	delirium	Disease	MESH:D003693
27662296	1323	1330	Abeta42	Gene	351
27662296	1380	1388	delirium	Disease	MESH:D003693
27662296	1421	1429	patients	Species	9606
27662296	1435	1443	dementia	Disease	MESH:D003704
27662296	1521	1529	delirium	Disease	MESH:D003693
27662296	1573	1580	Abeta42	Gene	351
27662296	1593	1609	beta-amyloidosis	Disease	MESH:D000686
27662296	1645	1662	neurodegeneration	Disease	MESH:D019636
27662296	1667	1679	hip fracture	Disease	MESH:D006620
27662296	1680	1688	patients	Species	9606
27662296	1697	1705	dementia	Disease	MESH:D003704
27662296	1717	1725	delirium	Disease	MESH:D003693
27662296	1753	1755	AD	Disease	MESH:D000544
27662296	1824	1832	delirium	Disease	MESH:D003693
27662296	Association	MESH:D003693	351
27662296	Negative_Correlation	MESH:D000686	351

